Regen BioPharma Inc (RGBP)
0.58
+0.02
(+3.57%)
USD |
OTCM |
May 10, 11:56
Regen BioPharma Shareholders Equity (Quarterly): -5.176M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.176M |
| December 31, 2023 | -5.242M |
| September 30, 2023 | -5.104M |
| June 30, 2023 | -5.029M |
| February 28, 2023 | -4.930M |
| December 31, 2022 | -4.885M |
| September 30, 2022 | -8.036M |
| June 30, 2022 | -8.350M |
| March 31, 2022 | -76.75M |
| December 31, 2021 | -9.756M |
| September 30, 2021 | -13.49M |
| June 30, 2021 | -10.54M |
| March 31, 2021 | -5.071M |
| December 31, 2020 | -5.581M |
| September 30, 2020 | -7.335M |
| June 30, 2020 | -8.559M |
| March 31, 2020 | -11.77M |
| December 31, 2019 | -7.699M |
| September 30, 2019 | -10.91M |
| June 30, 2019 | -12.80M |
| March 31, 2019 | -8.825M |
| Date | Value |
|---|---|
| December 31, 2018 | -8.664M |
| September 30, 2018 | -9.122M |
| June 30, 2018 | -8.575M |
| March 31, 2018 | -8.838M |
| December 31, 2017 | -7.800M |
| September 30, 2017 | -5.251M |
| June 30, 2017 | -4.019M |
| March 31, 2017 | -1.464M |
| December 31, 2016 | -0.1561M |
| September 30, 2016 | -0.5869M |
| June 30, 2016 | -0.5014M |
| March 31, 2016 | -0.2554M |
| December 31, 2015 | -0.022M |
| September 30, 2015 | -0.0972M |
| June 30, 2015 | 0.0827M |
| March 31, 2015 | 0.3547M |
| December 31, 2014 | -0.2614M |
| September 30, 2014 | -0.1296M |
| June 30, 2014 | -0.0058M |
| March 31, 2014 | 0.1152M |
| September 30, 2013 | 0.1159M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-76.75M
Minimum
Mar 2022
-4.885M
Maximum
Dec 2022
-11.35M
Average
-7.868M
Median
Shareholders Equity (Quarterly) Benchmarks
| CervoMed Inc | 7.377M |
| GlucoTrack Inc | 3.197M |
| AIM ImmunoTech Inc | 10.23M |
| Protalix BioTherapeutics Inc | 33.57M |
| Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1408M |
| Total Liabilities (Quarterly) | 5.317M |
| Debt to Equity Ratio | -0.134 |
| Current Ratio | 0.0238 |
| Net Debt Paydown Yield | -1.18% |